and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology.

Alzheimer's disease causes dementia which impairs the cognitive domains. The pharmacokinetic characteristics and biological activity of echinocystic acid are predicted in this work using or computational approaches, including pkCSM, Swiss ADME, OSIRIS property explorer, PASS online web resource and MOLINSPIRATION software. The compound has lipid metabolism regulating property as major role in decreasing the progression of Alzheimer's disease and it has no major side effects and ADR. The drug also has anti-inflammatory properties which can help in regulating the innate immunity that plays a major role in Alzheimer's disease. From the computational screening, we infer that, echinocystic acid can regulate memory loss, cognitive disability and also slow down the progression of Alzheimer's disease-like pathology.